A Phase 2a Study to Evaluate the Clinical Effect, Pharmacokinetics, Safety and Tolerability of Topically Applied Umeclidinium in Subjects With Primary Palmar Hyperhidrosis
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Umeclidinium (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Stiefel Laboratories
- 20 Dec 2016 Status changed from active, no longer recruiting to completed.
- 28 Nov 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.
- 28 Nov 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2016.